Showing 13,841 - 13,860 results of 49,729 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 13841

    Flow diagram of study procedure. by Yejung Ko (16548415)

    Published 2023
    “…The experimental group engaged in distance laughter therapy, a technique designed to stimulate self-induced laughter, while the control group viewed a 50-minute entertainment TV show. …”
  2. 13842
  3. 13843

    The small molecule Scaff10-8 inhibits the interaction of the DH domain of AKAP-Lbc and RhoA. by Katharina Schrade (4801266)

    Published 2018
    “…(B) In the HTRF from (A), Scaff10-8 inhibited the interaction of AKAP-Lbc/DHPH and RhoA with an IC<sub>50</sub> = 34.1 μM whereas Scaff10-59 did not (example of a negative Scaff10 derivative). …”
  4. 13844
  5. 13845
  6. 13846
  7. 13847
  8. 13848
  9. 13849
  10. 13850

    The hepatic cellular environment is altered with PLD inhibitors. by Karen M. Henkels (3350273)

    Published 2016
    “…Xenotransplanted MDA-MB-231 cells in the presence of vehicle, FIPI or VU0155072-2, respectively, and no xenotransplantation in the presence of vehicle. (<b>A-D</b>) Scale bar = 50 μm. (<b>E-Q</b>) Scale bar = 200 μm. …”
  11. 13851
  12. 13852

    The E2F pathway is activated in 5FU-treated Δ40p53:WTp53 cells. by Cecilia B. Levandowski (11238230)

    Published 2021
    “…<b>(D)</b> Cell cycle analysis (PI); chart (inset) represents the average of 3 experiments (bars = standard error of mean). Arrow highlights increased S phase in 5FU-treated p53 null MCF10a cells. …”
  13. 13853
  14. 13854

    Mass spectrum of 7-MH. by Juthamart Maneenet (15999769)

    Published 2025
    “…This study evaluated the anti-cancer potential of 7-methoxyheptaphylline (7-MH), a carbazole alkaloid from <i><i>Clausena harmandiana</i></i>, against pancreatic cancer cells (PANC-1) and developed an environmentally sustainable extraction methodology using ultrasonic-assisted extraction (UAE). 7-MH demonstrated selective cytotoxicity against PANC-1 cells with preferential activity under nutrient deprivation conditions (PC<sub>50</sub> = 4.54 μM) compared to nutrient-rich conditions (IC<sub>50</sub> = 46.84 μM). …”
  15. 13855

    ANOVA for 7-MH yield. by Juthamart Maneenet (15999769)

    Published 2025
    “…This study evaluated the anti-cancer potential of 7-methoxyheptaphylline (7-MH), a carbazole alkaloid from <i><i>Clausena harmandiana</i></i>, against pancreatic cancer cells (PANC-1) and developed an environmentally sustainable extraction methodology using ultrasonic-assisted extraction (UAE). 7-MH demonstrated selective cytotoxicity against PANC-1 cells with preferential activity under nutrient deprivation conditions (PC<sub>50</sub> = 4.54 μM) compared to nutrient-rich conditions (IC<sub>50</sub> = 46.84 μM). …”
  16. 13856

    Raw images of Western blot experiment. by Juthamart Maneenet (15999769)

    Published 2025
    “…This study evaluated the anti-cancer potential of 7-methoxyheptaphylline (7-MH), a carbazole alkaloid from <i><i>Clausena harmandiana</i></i>, against pancreatic cancer cells (PANC-1) and developed an environmentally sustainable extraction methodology using ultrasonic-assisted extraction (UAE). 7-MH demonstrated selective cytotoxicity against PANC-1 cells with preferential activity under nutrient deprivation conditions (PC<sub>50</sub> = 4.54 μM) compared to nutrient-rich conditions (IC<sub>50</sub> = 46.84 μM). …”
  17. 13857

    Prospective evaluation of a rapid diagnostic test for <i>Trypanosoma brucei gambiense</i> infection developed using recombinant antigens by Crispin Lumbala (334969)

    Published 2018
    “…A total of 57,632 individuals were screened in the Democratic Republic of the Congo, either passively at 10 health centres, or actively by 5 mobile teams, and 260 HAT cases were confirmed by parasitology. …”
  18. 13858
  19. 13859
  20. 13860

    S1 Graphical abstract - by Jennifer Astley (19859612)

    Published 2024
    “…</p><p>Results</p><p>Population structure did not appear to affect the timeline of elimination targets and screening individuals over the age of 30 at a high (50% per year) coverage could bring forward achievement of the incidence elimination target by four years compared to baseline (approximately 6% per year). …”